Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析

◆英語タイトル:Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME710FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Henry Schein Inc (HSIC) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Henry Schein Inc (Henry Schein) is a provider of health care products and services to dental and medical practitioners. Its product portfolio consists of preventatives, infection-control products, composites, anaesthetics, dental implants, generic and branded drugs, vaccines, surgical products and diagnostic tests, among others. It also offers technology solutions such as practice management software; and e-commerce solutions, equipment repair, financial services and other value-added services. The company serves dental practitioners, laboratories and physician practices, government, institutional health care clinics and other alternate care clinics across the world. It operates in Germany, Canada, France, Switzerland, the UK and the US, among others. Henry Schein is headquartered in New York, the US.

Henry Schein Inc Key Recent Developments

Apr 22,2021: Henry Schein CEO Stanley M. Bergman submits letter to congressional subcommittee supporting expanded COVID vaccine distribution
Apr 20,2021: Henry Schein to Webcast First Quarter 2021 Conference Call on Tuesday, May 4, 2021 at 10:00 A.M. Eastern Time
Mar 25,2021: Henry Schein furthers its commitment to accelerating vaccine equity by partnering with the Black Coalition against COVID-19
Mar 18,2021: Henry Schein CEO Stanley M. Bergman issues statement of support for congressional effort to expand COVID vaccine distribution
Mar 08,2021: Henry Schein announces Reinstatement of Share Repurchase Program

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Henry Schein Inc – Key Facts
Henry Schein Inc – Key Employees
Henry Schein Inc – Key Employee Biographies
Henry Schein Inc – Major Products and Services
Henry Schein Inc – History
Henry Schein Inc – Company Statement
Henry Schein Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Henry Schein Inc – Business Description
Business Segment: Health Care Distribution
Overview
Performance
Key Stats
Business Segment: Technology and Value-Added Services
Overview
Performance
Key Stats
Geographical Segment: Other Countries
Target Markets
Performance
Geographical Segment: The US
Performance
Henry Schein Inc – Corporate Strategy
Henry Schein Inc – SWOT Analysis
SWOT Analysis – Overview
Henry Schein Inc – Strengths
Henry Schein Inc – Weaknesses
Henry Schein Inc – Opportunities
Henry Schein Inc – Threats
Henry Schein Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Henry Schein Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Henry Schein Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Henry Schein Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 22, 2021: Henry Schein CEO Stanley M. Bergman submits letter to congressional subcommittee supporting expanded COVID vaccine distribution
Apr 20, 2021: Henry Schein to Webcast First Quarter 2021 Conference Call on Tuesday, May 4, 2021 at 10:00 A.M. Eastern Time
Mar 25, 2021: Henry Schein furthers its commitment to accelerating vaccine equity by partnering with the Black Coalition against COVID-19
Mar 18, 2021: Henry Schein CEO Stanley M. Bergman issues statement of support for congressional effort to expand COVID vaccine distribution
Mar 03, 2021: Henry Schein donates more than 10 million Personal Protective Equipment items to Non-Governmental Organizations for front-line health care workers and social service providers
Feb 23, 2021: Ethisphere announces Henry Schein as one of the 2021 World’s Most Ethical Companies for the 10th Time
Feb 22, 2021: Henry Schein to Present at the 2021 Barclays Global Healthcare Conference
Feb 18, 2021: Henry Schein opens Customer Assistance Hotline in response to Winter Storms across the United States
Feb 17, 2021: Henry Schein Reports Fourth Quarter 2020 Financial Results From Continuing Operations
Feb 16, 2021: Henry Schein one appoints new Chief Executive Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Henry Schein Inc, Key Facts
Henry Schein Inc, Key Employees
Henry Schein Inc, Key Employee Biographies
Henry Schein Inc, Major Products and Services
Henry Schein Inc, History
Henry Schein Inc, Subsidiaries
Henry Schein Inc, Key Competitors
Henry Schein Inc, Ratios based on current share price
Henry Schein Inc, Annual Ratios
Henry Schein Inc, Annual Ratios (Cont...1)
Henry Schein Inc, Annual Ratios (Cont...2)
Henry Schein Inc, Interim Ratios
Henry Schein Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Henry Schein Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Henry Schein Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GISA GmbH:企業の戦略的SWOT分析
    GISA GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Premier Biomedical Inc (BIEI):製薬・医療:M&Aディール及び事業提携情報
    Summary Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develo …
  • Eloro Resources Ltd (ELO):企業の財務・戦略的SWOT分析
    Summary Eloro Resources Ltd (Eloro Resources) is a mining and minerals exploration and development company that offers mineral exploration and development services. The company acquires, explores and develops precious and base-metal resources properties across Quebec. It explores for titanium, silve …
  • Schlumberger Limited:戦略・SWOT・企業財務分析
    Schlumberger Limited - Strategy, SWOT and Corporate Finance Report Summary Schlumberger Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Investcorp Bank BSc (INVCORP):企業の財務・戦略的SWOT分析
    Investcorp Bank BSc (INVCORP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Chart Industries Inc (GTLS):企業の財務・戦略的SWOT分析
    Chart Industries Inc (GTLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務情報
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Vanda Pharmaceuticals Inc (VNDA):企業の財務・戦略的SWOT分析
    Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mondelez International Inc (MDLZ):企業の財務・戦略的SWOT分析
    Mondelez International Inc (MDLZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • FortisAlberta Inc.:企業の戦略的SWOT分析
    FortisAlberta Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)-医療機器分野:企業M&A・提携分析
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • ALLETE Inc (ALE)-エネルギー分野:企業M&A・提携分析
    Summary ALLETE, Inc. (ALLETE) is an energy company that operates varied businesses in the energy sector. It has interests in mining facilities; electricity generation, transmission, and distribution assets; and water management businesses. It provides energy in the upper Midwest in the US; and inves …
  • The Empire District Electric Company:発電所・企業SWOT分析
    The Empire District Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Dow Silicones Corp:企業の戦略的SWOT分析
    Dow Silicones Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Reliance Steel & Aluminum Co:企業の戦略・SWOT・財務情報
    Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report Summary Reliance Steel & Aluminum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Feldan Bio Inc-製薬・医療分野:企業M&A・提携分析
    Summary Feldan Bio Inc (Feldan) is a biotechnology company. It discovers, develops, manufactures and markets research therapeutic and industrial protein products. The company offers cell therapy products, genome editing products and research products. Its genome editing product includes recombinant …
  • Decathlon S.A.:企業の戦略・SWOT・財務情報
    Decathlon S.A. - Strategy, SWOT and Corporate Finance Report Summary Decathlon S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Trevena Inc (TRVN):製薬・医療:M&Aディール及び事業提携情報
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆